Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia

Published:2020-09-19 Issue:1 Volume:62 Page:158-166
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Mushtaq Muhammad Umair¹²^ORCID,Harrington Alexandra M.³,Chaudhary Sibgha Gull¹²,Michaelis Laura C.⁴,Carlson Karen-Sue B.⁴,Abedin Sameem⁴,Runass Lyndsey⁴,Callander Natalie S.¹²,Fallon Michael J.²,Juckett Mark¹²,Hall Aric C.¹²,Hematti Peiman¹²,Mattison Ryan J.¹²,Atallah Ehab L.⁴,Guru Murthy Guru Subramanian⁴

Affiliation:

1. Division of Hematology/Oncology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

2. University of Wisconsin Carbone Cancer Center, Madison, WI, USA

3. Department of Pathology, Medical College of Wisconsin, Milwaukee, WI, USA

4. Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA

Funder

University of Wisconsin Carbone Cancer Center

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1821009

Reference52 articles.

1. Program NCIS. Acute myeloid leukemia – cancer stat facts. 2019. Available from: https://seer.cancer.gov/statfacts/html/amyl.html.

2. How I treat refractory and early relapsed acute myeloid leukemia

3. Prognostic Index for Adult Patients With Acute Myeloid Leukemia in First Relapse

4. Validation of the European Prognostic Index for younger adult patients with acute myeloid leukaemia in first relapse

5. Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of cladribine in combination with busulfan and cyclophosphamide as an intensive conditioning regimen preceding allogeneic hematopoietic stem cell transplantation in relapsed or refractory acute myeloid leukemia;Transplant Immunology;2024-06

2. FLAG-Ida’ya Karşı FLAG-Dauno: Relaps/Refrakter Akut Lösemi Olgularında Bursa Uludağ Üniversitesi Deneyimi;Uludağ Üniversitesi Tıp Fakültesi Dergisi;2024-05-17

3. Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody–drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study;The Lancet Oncology;2024-03

4. Cladribine, cytarabine, and filgrastim based regimen in relapsed or refractory acute myeloid leukemia: A systematic review and meta-analysis;Medicine;2023-11-03

5. Infectious complications after intensive chemotherapy with CLAG-M versus 7+3 for AML and other high-grade myeloid neoplasms;Leukemia;2022-12-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3